Industry news

Latest News

OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary

From Oranienburg to the rest of the world: global market launch of Daxas

Straumann launches new CADCAM dental restoration system

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

QRxPharma to Sponsor Symposium at International Association for the Study of Pain Meetings

Bayer

PharmaNet Joins Medidata Solutions' CRO Partner Program

Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery

Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study

Prometheus Launches the First Serogenetic Test to Predict Risk of Complications from Crohn's Disease

More news... | RSS Feed...

Most Viewed

OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary

Publication of Phase II trial results of NGR-hTNF in liver cancer by the British Journal of Cancer

Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study

From Oranienburg to the rest of the world: global market launch of Daxas

Straumann launches new CADCAM dental restoration system

Bayer

Neuronetics selected by World Economic Forum as 2011 Technology Pioneer

Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain

Forest Laboratories, Inc. and Gedeon Richter Plc Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression

Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire